| 14.69 -0.186 (-1.25%) | 04-30 11:46 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 17.44 | 1-year : | 20.38 |
| Resists | First : | 14.93 | Second : | 17.44 |
| Pivot price | 14.18  |
|||
| Supports | First : | 14.2 | Second : | 13.75 |
| MAs | MA(5) : | 14.52 |
MA(20) : | 14.23 |
| MA(100) : | 15.47  |
MA(250) : | 17.18 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 89.6 |
D(3) : | 83.2 |
| RSI | RSI(14): 55.4 |
|||
| 52-week | High : | 21.07 | Low : | 13.6 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ KURE ] has closed below upper band by 8.4%. Bollinger Bands are 23% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 14.95 - 14.99 | 14.99 - 15.04 |
| Low: | 14.64 - 14.69 | 14.69 - 14.75 |
| Close: | 14.78 - 14.86 | 14.86 - 14.95 |
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Fri, 22 Mar 2024
What’s Reddit, and Why You Shouldn’t Care… - Legacy Research Group
Mon, 26 Feb 2024
3 Thematic China ETFs for An Uncertain Outlook - ETF Trends
Mon, 06 Nov 2023
China Agrees to Global Collaboration on Artificial Intelligence - ETF Trends
Tue, 31 Oct 2023
5 Biggest Pharmaceutical ETFs in 2023 - Investing News Network
Fri, 22 Sep 2023
China Sits Firmly Atop Global Innovation Index - ETF Trends
Sun, 12 Mar 2023
A Chinese healthcare ETF hopes to outperform the MSCI China A index - ETF Stream
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|